COPD is not a cardiovascular disease. It is a chronic lung disease that restricts airflow and makes breathing progressively harder. However, COPD and cardiovascular disease are so deeply intertwined that heart problems are one of the leading causes of death in people with COPD, and the two conditions share biological mechanisms, risk factors, and overlapping symptoms that can make them difficult to tell apart.
What COPD Actually Is
COPD stands for chronic obstructive pulmonary disease, and it primarily damages the lungs. The airways become inflamed and narrowed, the air sacs lose their elasticity, and excess mucus clogs the passages. The result is a progressive decline in the ability to move air in and out. The condition encompasses what used to be called emphysema (destruction of air sacs) and chronic bronchitis (chronic inflammation of the airways with mucus production). It is classified as a respiratory disease, not a cardiovascular one.
That said, the distinction can be misleading. COPD rarely stays confined to the lungs. The chronic inflammation it triggers spills into the bloodstream and affects multiple organ systems, with the heart and blood vessels taking some of the heaviest damage.
Why COPD Hits the Heart So Hard
Several biological pathways connect lung damage in COPD directly to cardiovascular problems. The most important is systemic inflammation. In COPD, the inflammatory process that damages lung tissue also releases inflammatory signals into the bloodstream. These signals promote the uptake of cholesterol into blood vessel walls, trigger the formation of atherosclerotic plaque, and impair the ability of blood vessels to relax and dilate normally. In other words, the same inflammation destroying your lungs is quietly accelerating heart disease.
Oxidative stress compounds the problem. Cigarette smoke and air pollution generate highly reactive molecules that damage cells throughout the body. In the lungs, these molecules destroy the lining of air sacs, break down protective proteins, and impair the surfactant that keeps airways open. In the heart and blood vessels, they reduce the availability of nitric oxide, a molecule that keeps arteries flexible. The result is stiffer, more damaged blood vessels that are prone to plaque buildup.
Low oxygen levels add a third layer of harm. When damaged lungs can no longer deliver enough oxygen, blood vessels in the lungs constrict. Over time, this constriction becomes permanent as the vessel walls thicken with new muscle growth. The right side of the heart, which pumps blood through the lungs, now has to work against much higher resistance. Eventually, the right ventricle enlarges, weakens, and can fail. This process, called cor pulmonale, is a direct consequence of lung disease creating heart disease. Under normal conditions, the resistance in pulmonary blood vessels is about one-tenth that of the rest of the body’s arteries. Chronic oxygen deprivation can dramatically increase that resistance.
There is also growing evidence that COPD damages the autonomic nerve fibers inside the chest that help regulate heart rhythm and rate. This cardiac autonomic dysfunction may help explain why arrhythmias are common in COPD patients.
How Often the Two Conditions Overlap
The overlap is striking. Between 20% and 60% of people with COPD also have coronary artery disease. Heart failure affects 7% to 42% of COPD patients, rates far higher than in the general population. Roughly 10% to 17% of people with a confirmed COPD diagnosis have had a heart attack, and COPD approximately doubles the overall risk of one.
Hypertension is especially common, with prevalence in COPD patients ranging from about 29% to 65% depending on the study population. The relationship runs both directions: 13% to 39% of people diagnosed with heart failure also have COPD.
In mild to moderate COPD, cardiovascular disease and lung cancer are actually the most common causes of death, not respiratory failure. In one major study of smokers with mild to moderate airflow obstruction, cardiovascular disease accounted for 22% of deaths while non-cancer respiratory disease caused only 8%. The lungs are what get diagnosed, but the heart is often what kills.
Symptoms That Look the Same
One of the trickiest aspects of the COPD-heart disease relationship is that the symptoms overlap almost completely. Shortness of breath during exertion, nighttime coughing, and sudden episodes of breathlessness while lying down are common to both conditions. No qualitative feature of breathlessness is unique to heart failure, which means you cannot distinguish the two based on how the breathing difficulty feels.
Unrecognized heart failure frequently mimics or accompanies COPD flare-ups. About 40% of COPD patients who need mechanical ventilation for a severe breathing crisis show evidence of left-sided heart dysfunction. Many of these cases go undetected because the lung disease gets all the clinical attention.
Even standard diagnostic tools get complicated. Chest hyperinflation from COPD makes the heart appear smaller on X-rays, masking the enlargement typical of heart failure. The same hyperinflation creates poor acoustic windows for echocardiograms, making it harder to image the heart through ultrasound. Changes in lung blood vessels can also hide the fluid patterns that normally signal heart failure on imaging.
How Doctors Sort It Out
Separating the two conditions requires targeted testing. Spirometry, a breathing test that measures how much air you can force out in one second relative to your total exhaled volume, remains the standard for confirming COPD. A ratio below 70% confirms airflow obstruction. This test works best when fluid retention from heart failure has been treated first, since excess fluid in the lungs can mimic obstruction.
For the heart side, a blood test measuring natriuretic peptides (BNP or NT-proBNP) is particularly useful. These proteins rise when the heart is under strain. Very low levels effectively rule out heart failure, while very high levels confirm it. In the middle range, doctors combine the blood test result with other clinical findings. When echocardiograms are technically limited by lung hyperinflation, cardiac MRI can precisely measure heart chamber size and function without the limitations imposed by COPD-affected lungs.
What Shared Risk Factors Drive Both
Smoking is the single largest shared risk factor. Cigarette smoke triggers the inflammatory cascade that damages both lung tissue and blood vessel linings. It activates platelets, making blood more prone to clotting, and it generates the oxidative stress that accelerates atherosclerosis. Quitting smoking is the most effective intervention for slowing progression of both diseases simultaneously. Even brief counseling from a healthcare provider improves quit rates, and nicotine replacement or medication reliably increases long-term success.
Air pollution, aging, physical inactivity, and genetic susceptibility to inflammation also raise the risk of both conditions. Because the risk factors stack on each other, a person developing COPD is almost always simultaneously developing cardiovascular risk, whether or not they realize it.
Managing Heart Risk When You Have COPD
Because heart disease is so common and so dangerous in people with COPD, cardiovascular screening is an important part of comprehensive COPD care. Blood pressure control follows standard guidelines, as there is no evidence that hypertension needs to be treated differently just because COPD is present. Exercise capacity testing, such as a six-minute walk test, serves double duty: it tracks both lung function and cardiovascular fitness, and poor performance on this test is a strong predictor of outcomes for both conditions.
The annual incidence of new heart failure among COPD patients runs between 3% and 4%, meaning that even if your heart is fine at diagnosis, regular monitoring matters. Pulse oximetry, which tracks blood oxygen levels, helps identify the chronic low oxygen that drives pulmonary hypertension and right-sided heart strain before symptoms become severe.
The core message is straightforward: COPD is classified as a lung disease, and that classification is accurate. But treating it as only a lung disease misses the bigger picture. The inflammation, oxygen deprivation, and vascular damage it causes make cardiovascular disease not just a common companion but one of the primary threats to survival in people living with COPD.